Recursion Pharmaceuticals, Inc. (BMV:RXRX)
67.00
+4.00 (6.35%)
At close: Feb 9, 2026
Recursion Pharmaceuticals Market Cap
Recursion Pharmaceuticals has a market cap or net worth of 35.6 billion as of February 10, 2026. Its market cap has decreased by -39.10% in one year.
Market Cap
35.60B
Enterprise Value
25.67B
Revenue
801.35M
Ranking
n/a
PE Ratio
n/a
Stock Price
67.00
Market Cap Chart
Since April 16, 2021, Recursion Pharmaceuticals's market cap has decreased from 101.17B to 35.60B, a decrease of -64.82%. That is a compound annual growth rate of -19.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 9, 2026 | 35.60B | -7.12% |
| Dec 31, 2025 | 38.32B | -31.02% |
| Dec 31, 2024 | 55.56B | 53.86% |
| Dec 29, 2023 | 36.11B | 26.67% |
| Dec 30, 2022 | 28.51B | -51.96% |
| Dec 31, 2021 | 59.35B | -41.34% |
| Apr 16, 2021 | 101.17B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Corporación Inmobiliaria Vesta | 44.67B |
| Alsea | 43.78B |
| Fibra Danhos | 42.65B |
| Orbia Advance Corporation | 39.69B |
| Grupo Profuturo | 35.29B |
| Grupo Lamosa | 35.02B |
| Fibra Mty, S.A.P.I. de C.V. | 34.20B |
| FIBRA Terrafina | 33.49B |